A flow cytometry-based proliferation assay for clinical evaluation of T-cell memory against SARS-CoV-2

In general, the method of choice for evaluating immunity against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is detection of antibodies against the virus in patient sera. However, this is not feasible in patients who do not produce antibodies, either due to a primary immunodeficienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lind Enoksson, Sara, Bergman, Peter, Klingström, Jonas, Boström, Fredrik, Da Silva Rodrigues, Rui, Winerdal, Malin Elisabeth, Marits, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484816/
https://www.ncbi.nlm.nih.gov/pubmed/34597619
http://dx.doi.org/10.1016/j.jim.2021.113159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484816/
https://www.ncbi.nlm.nih.gov/pubmed/34597619
http://dx.doi.org/10.1016/j.jim.2021.113159

Ejemplares similares